Literature DB >> 6594234

Susceptibility of Legionella spp. to imipenem and 27 other beta-lactam antibiotics.

G Ruckdeschel, W Ehret, A Ahl.   

Abstract

With 28 beta-lactam antibiotics the susceptibilities of 60 strains of Legionella spp. (49 Legionella pneumophila and 11 ATCC type strains of other Legionella species) were determined. Agar dilution testing was used on buffered charcoal-yeast extract agar to which 0.1% alpha-ketoglutarate was added. The most active of the penicillins tested were ampicillin (MIC = 0.06-8 mg/l) and temocilin (MIC = 0.125 - 16 mg/l); the most active cephalosporins were ceftazidime (MIC = 0.03 - 0.5 mg/l), HR 810 (MIC = 0.06 - 1 mg/l) and cefoxitin (MIC = 0.125 - 2 mg/l). Of all the drugs tested imipenem had the most pronounced activity (MIC = .0075 - 0.06 mg/l).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6594234     DOI: 10.1007/bf02017376

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  21 in total

1.  Activities of newer quinolones against Legionella group organisms.

Authors:  D Greenwood; A Laverick
Journal:  Lancet       Date:  1983-07-30       Impact factor: 79.321

2.  Antibiotic susceptibility of Legionella pneumophia Philadelphia-1 in cultured guinea-pig peritoneal macrophages.

Authors:  S Yoshida; Y Mizuguchi
Journal:  J Gen Microbiol       Date:  1984-04

3.  Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Clin Invest       Date:  1983-01       Impact factor: 14.808

4.  Demonstration of the agent of Legionnaires' disease in tissue.

Authors:  F W Chandler; M D Hicklin; J A Blackmon
Journal:  N Engl J Med       Date:  1977-12-01       Impact factor: 91.245

5.  Antimicrobial susceptibility of intracellular Legionella pneumophila.

Authors:  M A Bacheson; H M Friedman; C E Benson
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

6.  Antimicrobial susceptibility of Legionella pneumophila Serogroups I--IV.

Authors:  L D Saravolatz; D J Pohlod; E L Quinn
Journal:  Scand J Infect Dis       Date:  1980

7.  Intracellular multiplication of Legionella pneumophila in cultured human embryonic lung fibroblasts.

Authors:  M C Wong; E P Ewing; C S Callaway; W L Peacock
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

8.  Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

9.  In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin.

Authors:  V W Horadam; J D Smilack; C L Montgomery; J Werringloer
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

Review 10.  Legionnaires' disease: report of sixty-five nosocomially acquired cases of review of the literature.

Authors:  B D Kirby; K M Snyder; R D Meyer; S M Finegold
Journal:  Medicine (Baltimore)       Date:  1980-05       Impact factor: 1.889

View more
  7 in total

1.  In vitro activity of Ro 23-9424 against clinical isolates of Legionella species.

Authors:  P H Edelstein; M A Edelstein
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

2.  Imipenem/cilastatin.

Authors:  M Barza
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

Review 3.  In vitro activity of imipenem--a review.

Authors:  I Braveny
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

4.  In vitro extracellular and intracellular activities of clavulanic acid and those of piperacillin and ceftriaxone alone and in combination with tazobactam against clinical isolates of Legionella species.

Authors:  P H Edelstein; M A Edelstein
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

Review 5.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

6.  In vitro activities of ceftriaxone and fusidic acid against 13 isolates of Coxiella burnetii, determined using the shell vial assay.

Authors:  H Torres; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

7.  Comparative activities of piperacillin and tazobactam against clinical isolates of Legionella spp.

Authors:  L A Collins; C B Wennersten; M J Ferraro; R C Moellering; G M Eliopoulos
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.